Section Review: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Newer immunosuppressive drugs and other agents for the treatment of rheumatoid arthritis - An update
- 1 September 1995
- journal article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 4 (9) , 853-859
- https://doi.org/10.1517/13543784.4.9.853
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex.Proceedings of the National Academy of Sciences, 1994
- THE USE OF CYCLOSPORIN A IN RHEUMATOID ARTHRITIS: CONCLUSIONS OF AN INTERNATIONAL REVIEWRheumatology, 1994
- A Putative Sirolimus (Rapamycin) Effector ProteinBiochemical and Biophysical Research Communications, 1994
- RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORsCell, 1994
- A mammalian protein targeted by G1-arresting rapamycin–receptor complexNature, 1994
- The effects of Tenidap on cytokine induced proliferation of human synovial fibroblasts in vitro.Annals of the Rheumatic Diseases, 1994
- EFFECTS OF RAPAMYCIN IN EXPERIMENTAL ORGAN ALLOGRAFTINGTransplantation, 1993
- EFFECT OF A SHORT COURSE OF RAPAMYCIN, CYCLOSPORIN A, AND DONOR-SPECIFIC TRANSFUSION ON RAT CARDIAC ALLOGRAFT SURVIVALTransplantation, 1993
- Pathogenesis of rheumatoid arthritisThe Lancet, 1993
- MHC Class-II Molecules and AutoimmunityAnnual Review of Immunology, 1991